Kurz, S. G., Wolff, K. A., Hazra, S., Bethel, C. R., Hujer, A. M., Smith, K. M., . . . Bonomo, R. A. (2013). Can Inhibitor-Resistant Substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC Lead to Clavulanate Resistance?: A Biochemical Rationale for the Use of β-Lactam–β-Lactamase Inhibitor Combinations. American Society for Microbiology.
Chicago-stil citatKurz, Sebastian G., et al. Can Inhibitor-Resistant Substitutions in the Mycobacterium Tuberculosis β-Lactamase BlaC Lead to Clavulanate Resistance?: A Biochemical Rationale for the Use of β-Lactam–β-Lactamase Inhibitor Combinations. American Society for Microbiology, 2013.
MLA-referensKurz, Sebastian G., et al. Can Inhibitor-Resistant Substitutions in the Mycobacterium Tuberculosis β-Lactamase BlaC Lead to Clavulanate Resistance?: A Biochemical Rationale for the Use of β-Lactam–β-Lactamase Inhibitor Combinations. American Society for Microbiology, 2013.